Seth M. Birnbaum Joins Pharma Company Hallux Inc. Board of Directors

Veteran Bridgewater partner brings capital formation experience to company as it pioneers subungal treatment for tough-to-cure onychomycosis.(PRWeb May 18, 2022)Read the full story at https://www.prweb.com/releases/2022/05/prweb18679990.htm
Source: PRWeb: Medical Pharmaceuticals - Category: Pharmaceuticals Source Type: news